Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiashuo Wu

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Genes|January 21, 2023
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific SignaturesJi Li, Jiashuo Wu, Junwei Han
Bioinformatics (Oxford, England)|September 6, 2022
DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk networkJiashuo Wu, Xiangmei Li, Qian Wang, et al.
Regulatory Toxicology and Pharmacology : RTP|October 30, 2020
Safety evaluation of Eucommia ulmoides extractXiaomei Luo, Jiashuo Wu, Zhuangzhuang Li, et al.
NPJ Digital Medicine|June 3, 2026
Interpretable graph deep learning framework for drug synergy prediction by integrating functional and clinical similaritiesJiyin Lai, Jiashuo Wu, Yalan He, et al.
Journal of Translational Medicine|December 23, 2022
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapyJiayue Qiu, Xiangmei Li, Yalan He, et al.
Briefings in Bioinformatics|January 10, 2021
CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancerYuqi Sheng, Ying Jiang, Yang Yang, et al.
Briefings in Bioinformatics|September 5, 2022
A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapyXiangmei Li, Yalan He, Jiashuo Wu, et al.
Computational and Structural Biotechnology Journal|April 27, 2023
A pathway-based mutation signature to predict the clinical outcomes and response to CTLA-4 inhibitors in melanomaQian Wang, Xiangmei Li, Jiayue Qiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
CITMIC: Comprehensive Estimation of Cell Infiltration in Tumor Microenvironment based on Individualized Intercellular CrosstalkXilong Zhao, Jiashuo Wu, Jiyin Lai, et al.
Journal of Separation Science|July 15, 2022
Deciphering the chemical constituents of Shengjiang Xiexin decoction by ultrahigh-performance liquid chromatography-quadrupole/orbitrap high-resolution mass spectrometry and the impact of 20 characteristic components on multidrug resistance-associated protein 2 in the vesicular transport assayHuanyu Guan, Pengfei Li, Qian Wang, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Genes|January 21, 2023
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific SignaturesJi Li, Jiashuo Wu, Junwei Han
Bioinformatics (Oxford, England)|September 6, 2022
DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk networkJiashuo Wu, Xiangmei Li, Qian Wang, et al.
Regulatory Toxicology and Pharmacology : RTP|October 30, 2020
Safety evaluation of Eucommia ulmoides extractXiaomei Luo, Jiashuo Wu, Zhuangzhuang Li, et al.
NPJ Digital Medicine|June 3, 2026
Interpretable graph deep learning framework for drug synergy prediction by integrating functional and clinical similaritiesJiyin Lai, Jiashuo Wu, Yalan He, et al.
Journal of Translational Medicine|December 23, 2022
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapyJiayue Qiu, Xiangmei Li, Yalan He, et al.
Briefings in Bioinformatics|January 10, 2021
CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancerYuqi Sheng, Ying Jiang, Yang Yang, et al.
Briefings in Bioinformatics|September 5, 2022
A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapyXiangmei Li, Yalan He, Jiashuo Wu, et al.
Computational and Structural Biotechnology Journal|April 27, 2023
A pathway-based mutation signature to predict the clinical outcomes and response to CTLA-4 inhibitors in melanomaQian Wang, Xiangmei Li, Jiayue Qiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 5, 2024
CITMIC: Comprehensive Estimation of Cell Infiltration in Tumor Microenvironment based on Individualized Intercellular CrosstalkXilong Zhao, Jiashuo Wu, Jiyin Lai, et al.
Journal of Separation Science|July 15, 2022
Deciphering the chemical constituents of Shengjiang Xiexin decoction by ultrahigh-performance liquid chromatography-quadrupole/orbitrap high-resolution mass spectrometry and the impact of 20 characteristic components on multidrug resistance-associated protein 2 in the vesicular transport assayHuanyu Guan, Pengfei Li, Qian Wang, et al.
Pageof 4